Aoki D - Search Results

1

A phase II clinical trial of topotecan in Japanese patients with relapsed ovarian carcinoma.

Aoki D, Katsumata N, Nakanishi T, Kigawa J, Fujiwara K, Takehara K, Kamiura S, Hiura M, Hatae M, Sugiyama T, Ochiai K, Noda K. Aoki D, et al. Jpn J Clin Oncol. 2011 Mar;41(3):320-7. doi: 10.1093/jjco/hyq192. Epub 2010 Oct 25. Jpn J Clin Oncol. 2011. PMID: 20974678 Clinical Trial.

2

Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis: clinicopathologic evaluation.

Komiyama S, Aoki D, Tominaga E, Susumu N, Udagawa Y, Nozawa S. Komiyama S, et al. Among authors: aoki d. Gynecol Oncol. 1999 Mar;72(3):342-6. doi: 10.1006/gyno.1998.5284. Gynecol Oncol. 1999. PMID: 10053105

3

Carbohydrate epitopes and mucins expressed by 17 human ovarian carcinoma cell lines.

Tamada Y, Iida S, Aoki D, Nozawa S, Irimura T. Tamada Y, et al. Among authors: aoki d. Oncol Res. 1999;11(5):233-41. Oncol Res. 1999. PMID: 10608618

4

Cisplatin sensitivity of ovarian cancer in the histoculture drug response assay correlates to clinical response to combination chemotherapy with cisplatin, doxorubicin and cyclophosphamide.

Ohie S, Udagawa Y, Kozu A, Komuro Y, Aoki D, Nozawa S, Moossa AR, Hoffman RM. Ohie S, et al. Among authors: aoki d. Anticancer Res. 2000 May-Jun;20(3B):2049-54. Anticancer Res. 2000. PMID: 10928150

5

[The biological property of ovarian cancers is affected by endometriosis--with special reference to ovarian clear cell adenocarcinoma].

Aoki D, Komiyama S, Susumu N, Nozawa S. Aoki D, et al. Nihon Rinsho. 2001 Jan;59 Suppl 1:213-6. Nihon Rinsho. 2001. PMID: 11235169 Review. Japanese. No abstract available.

6

[Dose finding study of paclitaxel and carboplatin for ovarian cancer (JKTB)].

Yasuda M, Kimura E, Ochiai K, Tada S, Udagawa Y, Aoki D, Nozawa S, Kikuchi Y, Kita T, Nishida M, Tsunoda H. Yasuda M, et al. Among authors: aoki d. Gan To Kagaku Ryoho. 2001 Apr;28(4):493-8. Gan To Kagaku Ryoho. 2001. PMID: 11329783 Clinical Trial. Japanese.

7

A novel retinoid, 4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid (TAC-101), induces apoptosis of human ovarian carcinoma cells and shows potential as a new antitumor agent for clear cell adenocarcinoma.

Suzuki N, Aoki D, Oie S, Horiuchi M, Hasegawa Y, Ezawa S, Suzuki A, Susumu N, Hosoi F, Kitazato K, Nozawa S. Suzuki N, et al. Among authors: aoki d. Gynecol Oncol. 2004 Sep;94(3):643-9. doi: 10.1016/j.ygyno.2004.06.026. Gynecol Oncol. 2004. PMID: 15350353

8

HMOCC-1, a human monoclonal antibody that inhibits adhesion of ovarian cancer cells to human mesothelial cells.

Suzuki N, Aoki D, Tamada Y, Susumu N, Orikawa K, Tsukazaki K, Sakayori M, Suzuki A, Fukuchi T, Mukai M, Kojima-Aikawa K, Ishida I, Nozawa S. Suzuki N, et al. Among authors: aoki d. Gynecol Oncol. 2004 Nov;95(2):290-8. doi: 10.1016/j.ygyno.2004.06.024. Gynecol Oncol. 2004. PMID: 15491748

9

Clinical characteristics of prognostic factors in poorly differentiated (G3) endometrioid adenocarcinoma in Japan.

Kuwabara Y, Susumu N, Banno K, Hirao T, Kawaguchi M, Yamagami W, Suzuki N, Aoki D, Nozawa S. Kuwabara Y, et al. Among authors: aoki d. Jpn J Clin Oncol. 2005 Jan;35(1):23-7. doi: 10.1093/jjco/hyi003. Jpn J Clin Oncol. 2005. PMID: 15681600

10

Chemosensitivity testing of ovarian cancer using the histoculture drug response assay: sensitivity to cisplatin and clinical response.

Nakada S, Aoki D, Ohie S, Horiuchi M, Suzuki N, Kanasugi M, Susumu N, Udagawa Y, Nozawa S. Nakada S, et al. Among authors: aoki d. Int J Gynecol Cancer. 2005 May-Jun;15(3):445-52. doi: 10.1111/j.1525-1438.2005.15307.x. Int J Gynecol Cancer. 2005. PMID: 15882168 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

692 results

Search Page

Filters